Nevro Corp. (NVRO)
NYSE: NVRO · Real-Time Price · USD
4.230
-0.010 (-0.24%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nevro Employees
Nevro had 1,215 employees as of December 31, 2023. The number of employees increased by 128 or 11.78% compared to the previous year.
Employees
1,215
Change (1Y)
128
Growth (1Y)
11.78%
Revenue / Employee
$344,976
Profits / Employee
-$57,044
Market Cap
158.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Organigram Holdings | 984 |
Nutex Health | 800 |
The Joint | 794 |
Adaptimmune Therapeutics | 449 |
Gossamer Bio | 135 |
Alpha Tau Medical | 121 |
Fulcrum Therapeutics | 76 |
Atossa Therapeutics | 12 |
NVRO News
- 3 days ago - New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches - PRNewsWire
- 6 days ago - Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - PRNewsWire
- 9 days ago - Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PRNewsWire
- 9 days ago - Nevro Corp. (NVRO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Nevro Reports Third-Quarter 2024 Financial Results - PRNewsWire
- 22 days ago - New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy - PRNewsWire
- 5 weeks ago - Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024 - PRNewsWire
- 2 months ago - Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation - PRNewsWire